Delivery Order SPE2DB20D2104-SPE2DB22FT35J
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,306.92 firm fixed-price delivery order is for the supply of 4560488341 - Cevimeline HCL 30 mg capsules, a prescription medication. The contract has an ultimate completion date of April 5, 2023 and was awarded on April 4, 2023. AmerisourceBergen, a for-profit organization, is the prime contractor and does not have any set-aside designation. This...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $6,558.84 firm fixed-price delivery order is for 4,560,816,582 capsules of the drug Cevimeline HCL 30 mg, to be delivered by May 4, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to supply a range of pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,169.55 firm fixed-price delivery order is for the supply of 4,566,340 units of the prescription medication Cevimeline HCl 30 mg capsules. The contract has an ultimate completion date of November 6, 2024 and was awarded on November 5, 2024. There was no set-aside designation for this contract. AmerisourceBergen...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4561055140 Cevimeline HCL 30 mg capsules. The $3,630.50 firm fixed-price delivery order (SPE2DB23FT69B) has a completion date of May 26, 2023. It is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Cevimeline HCL 30 mg capsules. The $2,200.08 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA) and has an ultimate completion date of October 26, 2023. Amerisourcebergen Drug Corp is the prime contractor for this award, and it is not associated with any set-aside designation. The company's parent organization, Cencora, Inc., holds two significant...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Cevimeline HCL 30 mg capsules. The firm-fixed-price contract has a ceiling value of $1,505.52 and a completion date of July 7, 2022. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,344.44 firm-fixed-price delivery order is for the supply of Cevimeline Hydrochloride 30 mg capsules, a medication used to treat dry mouth. This specific award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which provides a...
- This is a $1,586.56 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the provision of CEVIMELINE HCL 30 MG CAPSULE 100S, a prescription medication. The award is not designated as a set-aside contract. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
- This federal contract award, with ID SPE2DB22D1017|SPE2DB24FE7GM, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,557.03 firm fixed-price delivery order is for the provision of 4562519587 - CEVIMELINE HCL 30 MG CAPSULE 100S, a generic pharmaceutical product. The contract has an ultimate completion date of October 18, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CEVIMELINE HCL 30 MG CAPSULE 100S, a pharmaceutical product. The contract has a firm fixed price of $1,338.62 and a completion date of June 24, 2025. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB22FT35JDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,716.00 firm fixed-price delivery order is for the supply of 4557860723 - Cevimeline HCL 30 mg Capsule 100s. The award has an ultimate completion date of July 22, 2022 and was made on July 21, 2022. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 7/21/22 |